# Pregnancy-associated metabolic adaptations in circulating monocytes and macrophages favor clearance functions

**Authors:** Fátima Merech, Daiana Rios, Ana Schafir, Ignacio Rojas Campión, Melisa Bentivegna, Juan Beauquis, María Catalina Lava, Eugenio Antonio Carrera Silva, Andrea Emilse Errasti, Melisa Fariz, Daniel Paparini, Aldo Squassi, Luciana D´Eramo, Rosanna Ramhorst, Claudia Pérez Leirós, Soledad Gori, Vanesa Hauk, Daiana Vota

PMC · DOI: 10.3389/fimmu.2026.1786324 · Frontiers in Immunology · 2026-03-06

## TL;DR

During pregnancy, monocytes undergo metabolic changes that enhance their ability to clear dead cells, possibly supporting immune tolerance and tissue remodeling.

## Contribution

The study reveals a novel immunometabolic program in maternal monocytes driven by trophoblast signals during early pregnancy.

## Key findings

- Pregnant monocytes show increased fatty acid uptake and lactate secretion without mitochondrial changes.
- Efferocytosis during pregnancy depends on fatty acid oxidation and is supported by trophoblast-derived signals.
- Trophoblast-conditioned media induces metabolic and functional changes in macrophages similar to those in pregnant monocytes.

## Abstract

Pregnancy requires coordinated immunometabolic adaptations that allow maternal immune tolerance while preserving tissue remodeling and host defense. Circulating monocytes contribute critically to these processes, yet how gestation shapes their metabolic state and functional specialization remains incompletely defined.

We investigated the metabolic and functional phenotype of maternal monocytes during earlymid pregnancy (1620 weeks of gestation) and explored the contribution of trophoblast-derived signals using an in vitro macrophage model and trophoblast-conditioned media.

Maternal circulation was enriched in CD14+CD16+ monocytes, accompanied by increased plasma lactate levels and elevated ex vivo lactate secretion by purified monocytes, without changes in mitochondrial mass or membrane potential. Monocytes from pregnant women displayed enhanced long-chain fatty acid uptake and increased expression of the fatty acid transporter CD36, while lipid droplet accumulation remained unchanged. Pregnancy-associated efferocytosis was dependent on fatty acid oxidation (FAO), as pharmacological FAO inhibition abrogated this response. Transcriptional profiling revealed differential regulation of TAM receptors, characterized by increased MERTK and reduced AXL expression, consistent with a homeostatic efferocytic program. Trophoblast-derived conditioned media recapitulated key features of this phenotype in macrophages, inducing fatty acid uptake, lipid dropletmitochondria colocalization, and upregulation of CPT1, DGAT1, LXRa and RARa. In this model, FAO was required to sustain ATP production and M2-like marker expression, while monocarboxylate transport was necessary for efficient efferocytosis and fatty acid uptake.

Together, these findings identify a coordinated immunometabolic program in maternal monocytes integrating glycolysis, lactate signaling, and FAO, likely instructed by trophoblast-derived cues, to enhance efferocytic and pro-resolving functions during pregnancy. This metabolic adaptation may represent a systemic mechanism supporting immune tolerance and tissue remodeling in early gestation.

## Linked entities

- **Genes:** CD36 (CD36 molecule (CD36 blood group)) [NCBI Gene 948], CPT1A (carnitine palmitoyltransferase 1A) [NCBI Gene 1374], DGAT1 (diacylglycerol O-acyltransferase 1) [NCBI Gene 8694], NR1H3 (nuclear receptor subfamily 1 group H member 3) [NCBI Gene 10062], RARA (retinoic acid receptor alpha) [NCBI Gene 5914], MERTK (MER proto-oncogene, tyrosine kinase) [NCBI Gene 10461], AXL (AXL receptor tyrosine kinase) [NCBI Gene 558]
- **Proteins:** CD14 (CD14 molecule), FCGR3B (Fc gamma receptor IIIb)

## Full-text entities

- **Genes:** RARA (retinoic acid receptor alpha) [NCBI Gene 5914] {aka NR1B1, RAR, RARalpha}, MERTK (MER proto-oncogene, tyrosine kinase) [NCBI Gene 10461] {aka MER, RP38, Tyro12, c-Eyk, c-mer}, CD14 (CD14 molecule) [NCBI Gene 929], FCGR3A (Fc gamma receptor IIIa) [NCBI Gene 2214] {aka CD16-II, CD16A, FCG3, FCGR3, FCRIIIA, FcGRIIIA}, NR1H3 (nuclear receptor subfamily 1 group H member 3) [NCBI Gene 10062] {aka LXR-a, LXRA, RLD-1}, CPT1A (carnitine palmitoyltransferase 1A) [NCBI Gene 1374] {aka CPT I, CPT1, CPT1-L, CPTI-L, L-CPT1}, AXL (AXL receptor tyrosine kinase) [NCBI Gene 558] {aka ARK, AXL3, JTK11, Tyro7, UFO}, DGAT1 (diacylglycerol O-acyltransferase 1) [NCBI Gene 8694] {aka ARAT, ARGP1, DGAT, DIAR7}
- **Chemicals:** ATP (MESH:D000255), lipid (MESH:D008055), long-chain fatty acid (-), lactate (MESH:D019344), fatty acid (MESH:D005227)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13002387/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13002387/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC13002387/full.md

---
Source: https://tomesphere.com/paper/PMC13002387